Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Charles River Laboratories to Participate in September Investor Conferences


Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at three upcoming investor conferences, including:

  • Wells Fargo 2021 Healthcare Conference on Thursday, September 9th, at 10:00 a.m. EDT;
  • Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13th, at 10:15 a.m. EDT; and
  • Baird 2021 Global Healthcare Conference on Tuesday, September 144h, at 10:15 a.m. EDT.

Management will present an overview of Charles River’s strategic focus and business developments.

A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after each presentation and will remain available for approximately two weeks.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210907005046/en/

Charles River Labs Intl Aktie

197,25 €
-0,33 %
Die Charles River Labs Intl Aktie verzeichnet heute einen kleinen Rückgang um -0,33 %.
Die Charles River Labs Intl Aktie genießt klare Unterstützung: Mehrere Buy-Einschätzungen, keine Sell-Einschätzungen.
Bei einem Kursziel von 249 € ergibt sich ein positives Potenzial von 26.24% für Charles River Labs Intl im Vergleich zum aktuellen Kurs von 197.25 €.
Like: 0
Teilen
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Rechtlicher Hinweis

Kommentare